Pharmaceutical Automation Sector Poised to Hit $18.2 Billion by 2029
Meticulous
Research®—leading global market research company published a research report
titled, ‘Pharmaceutical Automation Market by Component (Plant-level Controls,
Enterprise-level Controls, Plant Instrumentation), Mode of Automation
(Semi-automatic, Fully-automatic), End User and Geography - Global
Forecast to 2029.’
Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=5280?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=23-10-2024
The pharmaceutical automation market is set to reach $18.2 billion by 2029, growing at a steady CAGR of 12% from 2022 to 2029. This remarkable growth is fueled by the increasing integration of robots into pharmaceutical manufacturing, strong government backing for industrial automation initiatives, and investments in modernizing production facilities. The demand for more secure, digitalized processes, along with the production surge for COVID-19 vaccines, is further propelling market growth.
The rise of the Industrial Internet of Things (IIoT) within pharmaceutical manufacturing is creating new opportunities by streamlining operations and enhancing efficiency. However, the market faces hurdles such as high upfront costs for automation hardware and software, a shortage of skilled labor, and cybersecurity concerns that may impede growth.
The market is categorized by components, modes of automation, and end-users. Enterprise-level control systems are expected to capture the largest share, given their ability to optimize productivity. Semi-automatic systems will likely dominate due to their cost-effectiveness, while the pharmaceutical industry remains the largest end-user segment, emphasizing the need for efficiency improvements and continuous process enhancements.
Asia-Pacific is expected to lead the global market, with countries like China, Japan, and Singapore emerging as key players due to their advanced technical capabilities. Thailand’s Mahidol University has implemented ABB’s YuMi cobots to automate the handling of virus and antibody samples, showcasing the region’s technological advancements.
Key players shaping this market include ABB Group, Rockwell Automation, Siemens AG, Yaskawa Electric Corporation, Schneider Electric, and Emerson Electric, among others.
About Meticulous
Research®:
Meticulous Research® was founded in 2010 and
incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private
limited company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market intelligence in North
America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services,
strengths, and values. Since the inception, we have only thrived to research,
analyze, and present the critical market data with great attention to details.
With the meticulous primary and secondary research techniques, we have built
strong capabilities in data collection, interpretation, and analysis of data
including qualitative and quantitative research with the finest team of
analysts. We design our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research, and
consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment